FDA amended EUA for Hologicﾒs Aptima SARS-CoV-2 assay to Include COVID-19 testing of asymptomatic individuals
On Oct. 6, 2020, Hologic announced that its Aptimaﾮ SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA)…
-
-
Vaxxas announced $22 million award from U.S. Government to advance Vaxxas Needle-Free HD-MAP vaccine patch
On Oct. 5, 2020, Vaxxas announced a $22 million United States government award to support the deployment of…
-
The Nobel Prize in Chemistry for 2021 was awarded to Benjamin List and David MacMillan
On Oct. 5, 2021, the Nobel Prize in Chemistry 2020 was awarded to Benjamin List and David MacMillan…
-
Mateon initiated commercialization of Artshield
On Oct. 5, 2020, Mateon Therapeutics announced that ArtiShieldTM had been approved for manufacture and marketing by the…
-
The Nobel Prize in Medicine for 2020 was awarded to Harvey J Alter, Michael Houghton and Charles M Rice
On Oct. 5, 2020, the Nobel Prize in Medicine 2020 was awarded to Harvey J. Alter, Michael Houghton…
-
FDA awarded contract to Stanford University to perform in-depth analysis of tissue samples to learn how SARS-CoV-2 causes COVID-19
On Oct. 5, 2020, the FDA awarded a research contract to the Stanford University School of Medicine to…
-
The CDC updated ‘how COVID is spread’
On Oct. 5, 2020, the CDC announced the existence of published reports that showed limited, uncommon circumstances where…
-
CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environments
On Oct. 5, 2020, CLEAR, the secure identity company, and Quest Diagnostics announced a new collaboration that aimed…
-
CLEAR adds LabCorp COVID-19 test results to ﾓHealth Passﾔ mobile app
On Oct. 5, 2020, CLEAR, the secure identity company, and LabCorp announced a partnership to enable users of…
-
NIH awarded $138 million for studies on the prevention and treatment of Alzheimer’s disease
On Oct. 5, 2020, Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert…
-
Fred Hutch opened COVID-19 clinical research center
On Oct. 5, 2020, the Fred Hutchinson Cancer Research Center announced the opening of the COVID-19 Clinical Research…
-
Bristol Myers Squibb to acquire MyoKardia for $131 billion in cash
On Oct. 5, 2020, Bristol-Myers and MyoKardia announced a definitive merger agreement under which Bristol Myers Squibb will…
-
Data from Corvus phase 1 study of CPI-006 continued to support its potential as treatment for COVID-19
On Oct. 5, 2020, Corvus Pharmaceuticals announced that it has initiated a Phase 1 study to investigate a…
-
LabCorp COVID-19 molecular test innovation received FDA authorization
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the FDA…
-
UConn funded five COVID-19 research projects, announced additional funding
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) (OVPR) announced a new…
-
Yale PET Center received $102 million BRAIN Initiative grant to build new scanner
On Oct. 2, 2020, Yale scientists announced construction of the next-generation human brain PET scanner, the NeuroeXplorer (NX),…
-
FDA approved drug combination for treating mesothelioma
On Oct. 1, 2020, the FDA approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment…
-
Humanigen announced COVID-19 case report demonstrated rapid resolution after single IND EUA of Lenzilumabﾙ
On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabﾙ in critical…
-
Quidel received Emergency Authorization for rapid antigen ‘ABC test’ assay for Influenza A+B and COVID-19
On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…
-
WHO welcomed $90 million contribution from Kingdom of Saudi Arabia to support COVID-19 global response
On Oct. 2, 2020, the WHO and the Kingdom of Saudi Arabia signed a contribution agreement in the…
-
COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…
-
National Science Foundation announced investment of $40 million in future of US manufacturing
On Oct. 2, 2020, the National Science Foundation announced investments in 24 new projects to drive future manufacturing….
-
Gilead Sciences updated supply and distribution of Vekluryﾮ (remdesivir) in the US
On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….
-
19 organizations from the healthcare community unite to form COVID-19 testing industry consortium
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
-
Amyris delivered sustainable alternative to shark squalene adjuvant enabling vaccines with no sharks killed
On Oct. 1, 2020, Amyris announced that it has begun delivering samples to pharmaceutical companies of a sustainable…
-
Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billion
On Oct. 1, 2020, Johnson & Johnson announced it had successfully completed its acquisition of Momenta Pharmaceuticals, a…
-
Veklury (remdesivir) made available directly from distributor
On Oct. 1, 2020, american hospitals began purchasing Veklury (remdesivir) directly from the drugﾒs distributor. Veklury is an…
-
BioNTech and Pfizer announced Nature publication of German phase 1/2 study data from mRNA-based vaccine candidate against SARS-CoV-2
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
-
Hydroxychloroquine showed no benefit in COVID-19 prevention
On Sept. 30, 2020, researchers from the Perelman School of Medicine at the University of Pennsylvania reported results…
-
BD announced CE Mark of portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes
On Sept. 30, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
